Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnostic performance of tomosynthesis plus synthetic mammography versus full-field digital mammography with or without tomosynthesis in breast cancer screening: A systematic review and meta-analysis.
Hamad W, Michell MJ, Myles JP, Gilbert FJ, Chen Y, Jin H, Loveland J, Halling-Brown M, Satchithananda K, Morel J, Wasan R, Taylor C, Sharma N, Valencia A, Teh W, Majid F, De Visser RM, Iqbal A, Duffy SW. Hamad W, et al. Among authors: myles jp. Int J Cancer. 2024 Oct 12. doi: 10.1002/ijc.35217. Online ahead of print. Int J Cancer. 2024. PMID: 39394862
Impact of pathologic re-review on grade, clinical stage, and risk stratification for patients with nonmuscle invasive bladder cancer.
Campbell RA, Wood A, Michael PD, Shin D, Pramod N, Haywood SC, Eltemamy M, Weight C, Haber GP, Lee B, Myles J, McKenney J, Nguyen J, Williamson SR, Przybycin C, Alaghehbandan R, Almassi N. Campbell RA, et al. Among authors: myles j. Urol Oncol. 2024 Nov;42(11):372.e21-372.e27. doi: 10.1016/j.urolonc.2024.05.020. Epub 2024 Jun 15. Urol Oncol. 2024. PMID: 38880703 Free article.
GM1 gangliosidosis type II: Results of a 10-year prospective study.
D'Souza P, Farmer C, Johnston JM, Han ST, Adams D, Hartman AL, Zein W, Huryn LA, Solomon B, King K, Jordan CP, Myles J, Nicoli ER, Rothermel CE, Mojica Algarin Y, Huang R, Quimby R, Zainab M, Bowden S, Crowell A, Buckley A, Brewer C, Regier DS, Brooks BP, Acosta MT, Baker EH, Vézina G, Thurm A, Tifft CJ. D'Souza P, et al. Among authors: myles j. Genet Med. 2024 Jul;26(7):101144. doi: 10.1016/j.gim.2024.101144. Epub 2024 Apr 16. Genet Med. 2024. PMID: 38641994
GM1 Gangliosidosis Type II: Results of a 10-Year Prospective Study.
D'Souza P, Farmer C, Johnston J, Han ST, Adams D, Hartman AL, Zein W, Huryn LA, Solomon B, King K, Jordan C, Myles J, Nicoli ER, Rothermel CE, Algarin YM, Huang R, Quimby R, Zainab M, Bowden S, Crowell A, Buckley A, Brewer C, Regier D, Brooks B, Baker E, Vézina G, Thurm A, Tifft CJ. D'Souza P, et al. Among authors: myles j. medRxiv [Preprint]. 2024 Jan 4:2024.01.04.24300778. doi: 10.1101/2024.01.04.24300778. medRxiv. 2024. Update in: Genet Med. 2024 Jul;26(7):101144. doi: 10.1016/j.gim.2024.101144 PMID: 38313286 Free PMC article. Updated. Preprint.
Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit.
Hayes DF, Herbst RS, Myles JL, Topalian SL, Yohe SL, Aronson N, Bellizzi AM, Basu Roy U, Bradshaw G, Edwards RH, El-Gabry EA, Elvin J, Gajewski TF, McShane LM, Oberley M, Philip R, Rimm DL, Rosenbaum JN, Rubin EH, Schlager L, Sherwood SW, Stewart M, Taube JM, Thurin M, Vasalos P, Laser J. Hayes DF, et al. Among authors: myles jl. JCO Precis Oncol. 2022 Nov;6:e2200454. doi: 10.1200/PO.22.00454. JCO Precis Oncol. 2022. PMID: 36446042 Free PMC article.
248 results